郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.

期刊：Journal of medicinal chemistry发表年份：2006作者：William F Kiesman; Jin Zhao; Patrick R Conlon; James E Dowling; Russell C Petter; Frank Lutterodt; Xiaowei Jin; Glenn Smits; Mary Fure; Andrew Jayaraj; John Kim; Gail Sullivan; Joel Linden
阅读更多 →

药效评价A direct approach to quantification of the cellular uptake of cell-penetrating peptides using MALDI-TOF mass spectrometry.

期刊：Nature protocols发表年份：2006作者：Fabienne Burlina; Sandrine Sagan; Gérard Bolbach; Gérard Chassaing
阅读更多 →

药效评价Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay.

期刊：Journal of biomolecular screening发表年份：2006作者：Mark Slack; Christian Kirchhoff; Clemens Moller; Dirk Winkler; Rainer Netzer
阅读更多 →

药效评价Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activity.

期刊：Molecular pharmacology发表年份：2006作者：Martin A Lewis; Lisa Hunihan; Diana Franco; Barbara Robertson; Jane Palmer; Denis R St Laurent; Balu N Balasubramanian; Yi Li; Ryan S Westphal
阅读更多 →